Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)
Clinical trial NCT02688803 · TERMINATED
Trial details
- NCT number
- NCT02688803
- Sponsor
- Ottawa Hospital Research Institute
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-30
- Primary completion
- 2017-10-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.